Creative Medical Technolo...

NASDAQ: CELZ · Real-Time Price · USD
2.02
0.00 (0.00%)
At close: May 19, 2025, 3:59 PM
2.02
0.00%
After-hours: May 19, 2025, 04:00 PM EDT

Creative Medical Technology Statistics

Share Statistics

Creative Medical Technology has 2.59M shares outstanding. The number of shares has increased by 88.11% in one year.

Shares Outstanding 2.59M
Shares Change (YoY) 88.11%
Shares Change (QoQ) 45.09%
Owned by Institutions (%) 0.23%
Shares Floating n/a
Failed to Deliver (FTD) Shares 7,394
FTD / Avg. Volume 7.28%

Short Selling Information

The latest short interest is 44.99K, so 1.74% of the outstanding shares have been sold short.

Short Interest 44.99K
Short % of Shares Out 1.74%
Short % of Float 1.77%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -0.62 and the forward PE ratio is -1.05. Creative Medical Technology's PEG ratio is 0.47.

PE Ratio -0.62
Forward PE -1.05
PS Ratio 310.89
Forward PS 0.1
PB Ratio 0.54
P/FCF Ratio -0.65
PEG Ratio 0.47
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Creative Medical Technology.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.73, with a Debt / Equity ratio of 0.

Current Ratio 18.73
Quick Ratio 18.72
Debt / Equity 0
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $2,750
Profits Per Employee $-1,373,370.25
Employee Count 4
Asset Turnover 0
Inventory Turnover 2.01

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -53.02% in the last 52 weeks. The beta is 4.85, so Creative Medical Technology's price volatility has been higher than the market average.

Beta 4.85
52-Week Price Change -53.02%
50-Day Moving Average 2.3
200-Day Moving Average 3.05
Relative Strength Index (RSI) 44.81
Average Volume (20 Days) 101,565

Income Statement

In the last 12 months, Creative Medical Technology had revenue of 11K and earned -5.49M in profits. Earnings per share was -3.71.

Revenue 11K
Gross Profit 6.6K
Operating Income -5.74M
Net Income -5.49M
EBITDA -5.63M
EBIT -5.74M
Earnings Per Share (EPS) -3.71
Full Income Statement

Balance Sheet

The company has 5.94M in cash and 0 in debt, giving a net cash position of 5.94M.

Cash & Cash Equivalents 5.94M
Total Debt n/a
Net Cash n/a
Retained Earnings -64.59M
Total Assets 8.35M
Working Capital 7.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.3M and capital expenditures 0, giving a free cash flow of -5.3M.

Operating Cash Flow -5.3M
Capital Expenditures n/a
Free Cash Flow -5.3M
FCF Per Share -3.58
Full Cash Flow Statement

Margins

Gross margin is 60%, with operating and profit margins of -52216.92% and -49940.74%.

Gross Margin 60%
Operating Margin -52216.92%
Pretax Margin -49940.74%
Profit Margin -49940.74%
EBITDA Margin -51212.81%
EBIT Margin -52216.92%
FCF Margin -48193.56%

Dividends & Yields

CELZ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for CELZ.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Jun 12, 2023. It was a backward split with a ratio of 1:10.

Last Split Date Jun 12, 2023
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -1.59
Piotroski F-Score 4